Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Lindsley

Showing results (81-90 of 570) with videos related to

Pageof 57
Sort By:
The Journal of Organic Chemistry|August 23, 2019
Formal Total Synthesis of Pericoannosin AMark G Fulton, Jeanette L Bertron, Carson W Reed, et al.
Current Topics in Medicinal Chemistry|September 17, 2009
Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's diseaseCraig W Lindsley, Colleen M Niswender, Darren W Engers, et al.
Current Opinion in Drug Discovery & Development|July 19, 2005
Recent advances in positive allosteric modulators of metabotropic glutamate receptorsWilliam D Shipe, Scott E Wolkenberg, David L Williams, et al.
The Journal of Biological Chemistry|November 22, 2013
Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cellsRonald C Bruntz, Harry E Taylor, Craig W Lindsley, et al.
ACS Chemical Neuroscience|February 28, 2012
Label-free detection of G protein-SNARE interactions and screening for small molecule modulatorsChristopher A Wells, Katherine M Betke, Craig W Lindsley, et al.
Organic Letters|October 5, 2017
Preparation of Unsymmetrical 1,2,4,5-Tetrazines via a Mild Suzuki Cross-Coupling ReactionAaron M Bender, Trevor C Chopko, Thomas M Bridges, et al.
Current Cancer Drug Targets|February 22, 2008
The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitorsCraig W Lindsley, Stanley F Barnett, Mark E Layton, et al.
ACS Chemical Neuroscience|August 4, 2012
Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeuticsAlbert J Robichaud, Darren W Engers, Craig W Lindsley, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|December 24, 2005
Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancerDonghwa Kim, George Z Cheng, Craig W Lindsley, et al.
Journal of Medicinal Chemistry|December 17, 2025
Recent Advances in Long-Acting Antiviral Agents: Innovations in Design and Strategies for Extended DurationShuo Wang, Feiyue Ma, Craig W Lindsley, et al.
Pageof 57

Showing results (81-90 of 570) with videos related to

Sort By:
Pageof 57
The Journal of Organic Chemistry|August 23, 2019
Formal Total Synthesis of Pericoannosin AMark G Fulton, Jeanette L Bertron, Carson W Reed, et al.
Current Topics in Medicinal Chemistry|September 17, 2009
Recent progress in the development of mGluR4 positive allosteric modulators for the treatment of Parkinson's diseaseCraig W Lindsley, Colleen M Niswender, Darren W Engers, et al.
Current Opinion in Drug Discovery & Development|July 19, 2005
Recent advances in positive allosteric modulators of metabotropic glutamate receptorsWilliam D Shipe, Scott E Wolkenberg, David L Williams, et al.
The Journal of Biological Chemistry|November 22, 2013
Phospholipase D2 mediates survival signaling through direct regulation of Akt in glioblastoma cellsRonald C Bruntz, Harry E Taylor, Craig W Lindsley, et al.
ACS Chemical Neuroscience|February 28, 2012
Label-free detection of G protein-SNARE interactions and screening for small molecule modulatorsChristopher A Wells, Katherine M Betke, Craig W Lindsley, et al.
Organic Letters|October 5, 2017
Preparation of Unsymmetrical 1,2,4,5-Tetrazines via a Mild Suzuki Cross-Coupling ReactionAaron M Bender, Trevor C Chopko, Thomas M Bridges, et al.
Current Cancer Drug Targets|February 22, 2008
The PI3K/Akt pathway: recent progress in the development of ATP-competitive and allosteric Akt kinase inhibitorsCraig W Lindsley, Stanley F Barnett, Mark E Layton, et al.
ACS Chemical Neuroscience|August 4, 2012
Recent progress on the identification of metabotropic glutamate 4 receptor ligands and their potential utility as CNS therapeuticsAlbert J Robichaud, Darren W Engers, Craig W Lindsley, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|December 24, 2005
Targeting the phosphatidylinositol-3 kinase/Akt pathway for the treatment of cancerDonghwa Kim, George Z Cheng, Craig W Lindsley, et al.
Journal of Medicinal Chemistry|December 17, 2025
Recent Advances in Long-Acting Antiviral Agents: Innovations in Design and Strategies for Extended DurationShuo Wang, Feiyue Ma, Craig W Lindsley, et al.
Pageof 57